日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下,新型雄激素受体抑制剂氘代沙鲁胺的疗效:来自随机 III 期 HC-1119-04 试验的结果

Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei

Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial

信迪利单抗联合阿昔替尼治疗晚期富马酸水合酶缺乏型肾细胞癌:一项 II 期非随机临床试验

Zhang, Xingming; Liu, Haoyang; Liang, Jiayu; Zhao, Junjie; Wang, Yongquan; Chen, Yuntian; Kang, Deying; Chen, Qian; Zhang, Yaowen; Yin, Xiaoxue; Zeng, Yuhao; Wang, Zilin; Sheng, Xinan; Yao, Xin; Gong, Kan; Liu, Xiaodong; Chen, Zhibin; Qiu, Mingxing; Chen, Wei; Wang, Zongping; Luo, Guangheng; Zhou, Tingting; Yang, Nanshan; Pan, Xiuyi; Nie, Ling; Zhang, Mengni; Chen, Junru; Zhao, Jinge; Hu, Xu; Xu, Lijing; Tang, Bo; Dai, Jindong; Liu, Haolin; Ni, Yuchao; Huang, Rui; Wei, Qiang; Li, Xiang; He, Qiying; Liu, Jiyan; Shen, Pengfei; Chen, Ni; Liu, Zhenhua; Sun, Guangxi; Yao, Jin; Zeng, Hao

FABP7-mediated lipid-laden macrophages drive the formation of pre-metastatic niche and liver metastasis.

FABP7 介导的脂质巨噬细胞驱动转移前微环境的形成和肝转移

Xu Shaowan, Peng Xin, Wang Zhenfang, Le Chenchen, Wu Xiangkun, Zeng Zhicheng, Zeng Sisi, Zhang Ceng, Qiu Mingxing, Zou Xin, Zhang Hongxia, Wang Feifei, Kang Wei, Ding Yanqing, Liang Li

A randomized study of apalutamide in Chinese patients with non-metastatic castration-resistant prostate cancer

一项针对中国非转移性去势抵抗性前列腺癌患者的阿帕鲁胺随机研究

Jiang, Shusuan; Tian, Ye; Guo, Hongqian; Guo, Jianming; Dong, Haiying; Luo, Hong; Xue, Wei; Xu, Tao; Li, Lei; Qiu, Mingxing; Xie, Liping; Lopez-Gitlitz, Angela; McCarthy, Sharon; Liu, Yanmei; Ma, Haocheng; Liang, Hongchuan; Li, Yanhui; Chen, Na; Ye, Dingwei

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer

戈舍瑞林10.8毫克缓释剂在中国局限性或局部晚期前列腺癌患者中的真实世界疗效和安全性

Chen, Nanhui; Wang, Zengjun; Chen, Ming; Ma, Qi; He, Yi; Wang, Yujie; Li, Xin; Qiu, Mingxing; Shi, Lei; Zhu, Shaoxing; Xie, Qun; Liu, Xiuheng; Shi, Benkang; Lin, Guowen; Yang, Weizhong; Liao, Yongbin; Zhang, Haibin; Wang, Shusheng; Li, Jiexian; Wang, Shaogang; Dong, Lijun; Chen, Hui; Lu, Jiaju; Cheng, Yongyi; Zhang, Xiaoping; Ma, Lulin; Zhou, Liqun; Wang, He; Li, Shen; Ye, Dingwei

Independent association between prostate-specific antigen nadir and PSA progression-free survival in first-line abiraterone acetate treatment in castration-resistant prostate cancer patients: a pilot study

去势抵抗性前列腺癌患者一线接受醋酸阿比特龙治疗后,前列腺特异性抗原最低值与PSA无进展生存期之间的独立关联:一项初步研究

Du, Hong; Xie, Wenjuan; Chen, Wenqiang; Wang, Yu; Liao, Yong; Qiu, Mingxing; Li, Jun

Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis

通过分子分析对结直肠癌肿瘤微环境进行全面表征

Wu, Xiangkun; Yan, Hong; Qiu, Mingxing; Qu, Xiaoping; Wang, Jing; Xu, Shaowan; Zheng, Yiran; Ge, Minghui; Yan, Linlin; Liang, Li

CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway

CRIP1 通过激活 Wnt/β-catenin 通路支持 AML-M5 亚型细胞的生长和迁移

Xiaoling Deng, Yanmei Zeng, Xiaofen Qiu, Mingxing Zhong, Xiujuan Xiong, Mansheng Luo, Jingdong Zhang, Xiaoli Chen

Identification of potential autophagy-associated lncRNA in prostate cancer

前列腺癌中潜在自噬相关长链非编码RNA的鉴定

Li, Jun; Du, Hong; Chen, Wenqiang; Qiu, Mingxing; He, Peng; Ma, Zhiwei

Expression of CD44 and the survival in glioma: a meta-analysis

CD44表达与胶质瘤患者生存率的关系:一项荟萃分析

Wu, Gang; Song, Xinghui; Liu, Jun; Li, Shize; Gao, Weiqin; Qiu, Mingxing; Yang, Changjin; Ma, Yiming; Chen, Yuhong